[
    [
        {
            "time": "2018-01-31",
            "original_text": "Here's Why Coherus BioSciences Rose 48.7% in January",
            "features": {
                "keywords": [
                    "Coherus",
                    "BioSciences",
                    "Rose",
                    "January"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "biotechnology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Here's Why Coherus BioSciences Rose 48.7% in January",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-01-31",
            "original_text": "5 High-Growth Stocks Undervalued by the Market",
            "features": {
                "keywords": [
                    "High-Growth",
                    "Stocks",
                    "Undervalued",
                    "Market"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "5 High-Growth Stocks Undervalued by the Market",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-01-31",
            "original_text": "Here's Why Coherus BioSciences Rose 48.7% in January",
            "features": {
                "keywords": [
                    "Coherus",
                    "BioSciences",
                    "Rose",
                    "January"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "biotechnology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Here's Why Coherus BioSciences Rose 48.7% in January",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-01-31",
            "original_text": "IWV, PEP, ABBV, AMGN: ETF Outflow Alert",
            "features": {
                "keywords": [
                    "IWV",
                    "PEP",
                    "ABBV",
                    "AMGN",
                    "ETF",
                    "Outflow"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance",
                    "consumer goods",
                    "pharmaceuticals",
                    "biotechnology"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "IWV, PEP, ABBV, AMGN: ETF Outflow Alert",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-01-31",
            "original_text": "AbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple Myeloma",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Teneobio",
                    "Strategic",
                    "Transaction",
                    "Multiple Myeloma"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "AbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple Myeloma",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-01-31",
            "original_text": "ABBV or CELG: Comparing Dividends, Interest Expenses, and Debt",
            "features": {
                "keywords": [
                    "ABBV",
                    "CELG",
                    "Dividends",
                    "Interest Expenses",
                    "Debt"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "ABBV or CELG: Comparing Dividends, Interest Expenses, and Debt",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]